Biomerica Inc (BMRA) shareholders
Close on Nov 17, 2026Market cap $5.68MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BRC Group Holdings, Inc. Joint filing with B. Riley Principal Capital, LLC (10.03%), Bryant R. Riley (10.03%) | 460,080 | 10.03% | 13D (active) | Aug 25, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BMRA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 26,374 | 0.57% | $46.00K | New | 0.00% |
| Geode Capital Management, LLC | 24,347 | 0.53% | $42.86K | −31,695 | 0.00% |
| BlackRock, Inc. | 18,636 | 0.41% | $32.80K | – | 0.00% |
| Vanguard Capital Management LLC | 14,514 | 0.32% | $25.55K | – | 0.00% |
| Jane Street Group, LLC | 12,640 | 0.27% | $22.25K | New | 0.00% |
| LPL Financial LLC | 10,849 | 0.24% | $19.09K | – | 0.00% |
| UBS Group AG | 6,951 | 0.15% | $12.23K | +6,432 | 0.00% |
| Vanguard Fiduciary Trust Co | 6,613 | 0.14% | $11.64K | – | 0.00% |
| NewEdge Advisors, LLC | 3,603 | 0.08% | $6.34K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 238 | 0.01% | $419 | New | 0.00% |
| Hollencrest Capital Management | 200 | 0.00% | $352 | −625 | 0.00% |
| Harbour Investments, Inc. | 125 | 0.00% | $220 | – | 0.00% |
| FMR LLC | 83 | 0.00% | $146 | New | 0.00% |
| IFG Advisory, LLC | 25 | 0.00% | $44 | New | 0.00% |
| Larson Financial Group LLC | 12 | 0.00% | $21 | New | 0.00% |
| Barclays PLC | 6 | 0.00% | $11 | New | 0.00% |
| MCF Advisors LLC | 6 | 0.00% | $11 | – | 0.00% |
| Federation des caisses Desjardins du Quebec | 3 | 0.00% | $5 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | 0.00% | $4 | New | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $2 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 20 | 0M | 2.7% | 9 / 1 | 2 / 0 | 0M | 0M |
| Q1 2026 | 11 | 0M | 2.4% | 4 / 1 | 2 / 4 | 0M | 0M |
| Q4 2025 | 13 | 0M | 1.9% | 0 / 5 | 1 / 4 | 0M | 0M |
| Q3 2025 | 17 | 0M | 1.9% | 6 / 1 | 3 / 1 | 0M | 0M |
| Q2 2025 | 12 | 0M | 1.5% | 1 / 4 | 5 / 13 | 0M | 0M |
| Q1 2025 | 24 | 0M | 2.6% | 6 / 3 | 6 / 3 | 0M | 0M |
| Q4 2024 | 21 | 0M | 3.8% | 5 / 3 | 4 / 8 | 0M | 0M |
| Q3 2024 | 25 | 0M | 4.4% | 4 / 0 | 12 / 13 | 0M | 0M |
| Q2 2024 | 35 | 0M | 6.1% | 6 / 5 | 9 / 7 | 0M | 0M |
| Q1 2024 | 36 | 0M | 10.1% | 9 / 8 | 7 / 4 | 0M | 0M |
| Q4 2023 | 33 | 0M | 10.2% | 4 / 13 | 8 / 6 | 0M | 0M |
| Q3 2023 | 35 | 0M | 10.9% | 3 / 5 | 12 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held BMRA in Q2 2026, 23% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BMRA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 42,943 | 0.93% | $104.35K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 14,514 | 0.32% | $25.54K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 3,489 | 0.08% | $8.48K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,719 | 0.04% | $4.18K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Zackary S. Irani | Chief Executive Officer, Director | 242,570 | 5.27% | Aug 27, 2026 |
| Allen Barbieri | Executive Vice Chairman, Director | 73,542 | 1.60% | Aug 27, 2026 |
| Xiaoxuan Qu | See Remarks | – | – | Sep 8, 2026 |
| Gary Lu | Chief Financial Officer | 59,375 | 1.29% | Dec 31, 2025 |
| Eric Chin | Director | 38,750 | 0.84% | Aug 27, 2026 |
| M. Huff Gary | Director | 51,250 | 1.11% | Aug 27, 2026 |
| David Moatazedi | Director | 40,625 | 0.88% | Aug 27, 2026 |
| Jane Emerson | Director | 156,000 | 3.39% | Dec 17, 2024 |
| Catherine Coste | Director | 137,890 | 3.00% | Dec 17, 2024 |
| Bryant R. Riley | 10% owner | – | – | Sep 10, 2026 |
| B. RILEY Principal Capital, LLC | 10% owner | – | – | Sep 10, 2026 |
| BRC Group Holdings, Inc. | 10% owner | 460,080 | 10.00% | Sep 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Zackary S. Irani Chief Executive Officer, Director | Aug 26, 2026 | Buy | +31,250 | $1.60 | $50.00K | 242,570 |
| David Moatazedi Director | Aug 26, 2026 | Buy | +10,000 | $1.60 | $16.00K | 40,625 |
| Allen Barbieri Executive Vice Chairman, Director | Aug 26, 2026 | Buy | +20,000 | $1.60 | $32.00K | 73,542 |
| Eric Chin Director | Aug 26, 2026 | Buy | +6,250 | $1.60 | $10.00K | 38,750 |
| M. Huff Gary Director | Aug 20, 2026 | Buy | +31,250 | $1.60 | $50.00K | 51,250 |
| Eric Chin Director | Dec 12, 2025 | Award | +22,500 | – | – | 32,500 |
| David Moatazedi Director | Dec 12, 2025 | Award | +20,000 | – | – | 30,625 |
| Gary Lu Chief Financial Officer | Dec 12, 2025 | Award | +40,000 | – | – | 59,375 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 12, 2025 | Award | +52,500 | – | – | 211,320 |
| M. Huff Gary Director | Dec 12, 2025 | Award | +20,000 | – | – | 20,000 |
| Allen Barbieri Executive Vice-Chairman, Director | Dec 12, 2025 | Award | +30,000 | – | – | 53,543 |
| David Moatazedi Director | Dec 13, 2024 | Award | +85,000 | $0.31 | $26.35K | 85,000 |
| Allen Barbieri Executive Vice Chairman, Director | Dec 13, 2024 | Award | +110,000 | $0.31 | $34.10K | 188,337 |
| Catherine Coste Director | Dec 13, 2024 | Award | +85,000 | $0.31 | $26.35K | 128,790 |
| Gary Lu Chief Financial Officer | Dec 13, 2024 | Award | +155,000 | $0.31 | $48.05K | 155,000 |
| Jane Emerson Director | Dec 13, 2024 | Award | +85,000 | $0.31 | $26.35K | 156,000 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 13, 2024 | Award | +250,000 | $0.31 | $77.50K | 1,270,560 |
| Allen Barbieri Vice Chairman, Director | Jan 2, 2024 | Gift | −15,000 | – | – | 78,337 |
| Allen Barbieri Vice Chairman, Director | Jun 27, 2023 | Gift | −8,000 | – | – | 93,327 |
| Zackary S. Irani Chief Executive Officer, Director | May 25, 2023 | Buy | +200 | $1.55 | $310 | 1,020,560 |
| Zackary S. Irani Chief Executive Officer, Director | May 24, 2023 | Buy | +500 | $1.61 | $805 | 1,020,360 |
| Zackary S. Irani Chief Executive Officer, Director | May 12, 2023 | Buy | +1,700 | $1.17 | $1.99K | 1,019,860 |
| Zackary S. Irani Chief Executive Officer, Director | May 10, 2023 | Buy | +500 | $1.27 | $635 | 1,018,160 |
| Zackary S. Irani Chief Executive Officer, Director | May 9, 2023 | Buy | +300 | $1.39 | $417 | 1,017,660 |
| Zackary S. Irani Chief Executive Officer, Director | May 4, 2023 | Buy | +1,000 | $1.36 | $1.36K | 1,017,360 |
| Zackary S. Irani Chief Executive Officer, Director | Apr 28, 2023 | Buy | +1,800 | $1.34 | $2.41K | 1,017,360 |
| Zackary S. Irani Chief Executive Officer, Director | Apr 27, 2023 | Buy | +2,600 | $1.31 | $3.41K | 1,017,360 |
| Zackary S. Irani Chief Executive Officer, Director | Apr 26, 2023 | Buy | +7,000 | $1.26 | $8.82K | 1,012,960 |
| Allen Barbieri Executive Vice Chairman, Director | Jan 27, 2023 | Buy | +1,538 | $2.94 | $4.52K | 101,327 |
| Catherine Coste Director | Jan 26, 2023 | Buy | +2,190 | $2.96 | $6.48K | 43,790 |
| Zackary S. Irani Chief Executive Officer, Director | Jan 25, 2023 | Buy | +1,800 | $2.85 | $5.13K | 1,005,960 |
| Zackary S. Irani Chief Executive Officer, Director | Jan 24, 2023 | Buy | +2,000 | $2.81 | $5.62K | 1,004,160 |
| Allen Barbieri Vice Chairman, Director | Nov 17, 2022 | Gift | −7,500 | – | – | 101,327 |
| Allen Barbieri Vice Chairman, Director | Dec 20, 2021 | Gift | −7,500 | – | – | 107,289 |
| Allen Barbieri Vice Chairman, Director | Mar 26, 2021 | Gift | −22,500 | – | – | 114,789 |
| Allen Barbieri Vice Chairman, Director | Mar 26, 2021 | Gift | −22,500 | – | – | 114,789 |
| Catherine Coste Director | Oct 26, 2020 | Buy | +9,100 | $5.45 | $49.60K | 9,100 |
| Francis Cano Director | Oct 5, 2020 | Gift | −20,000 | – | – | 146,736 |
| Mark A. Sirgo Director | Apr 21, 2020 | Sale | −5,000 | $8.11 | $40.55K | 8,700 |
| Mark A. Sirgo Director | Apr 17, 2020 | Sale | −1,302 | $8.07 | $10.51K | 16,154 |
| Mark A. Sirgo Director | Apr 17, 2020 | Sale | −68 | $8.09 | $550 | 18,632 |
| Mark A. Sirgo Director | Apr 17, 2020 | Sale | −100 | $8.06 | $806 | 18,532 |
| Mark A. Sirgo Director | Apr 17, 2020 | Sale | −2,454 | $8.08 | $19.83K | 13,700 |
| Mark A. Sirgo Director | Apr 17, 2020 | Sale | −1,076 | $8.05 | $8.66K | 17,456 |
| Allen Barbieri Director | Apr 1, 2020 | Gift | −23,000 | – | – | 137,289 |
| Zackary S. Irani Chief Executive Officer, Director | Feb 28, 2020 | Other | +78,431 | $2.85 | $223.53K | 1,002,160 |
| Janet Moore Chief Financial Officer, Director | Jan 2, 2020 | Gift | −20,000 | – | – | 101,720 |
| Janet Moore Chief Financial Officer, Director | Oct 28, 2019 | Gift | −3,000 | – | – | 121,720 |
| Janet Moore Chief Financial Officer, Director | Apr 23, 2019 | Gift | −16,000 | – | – | 124,720 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 21, 2018 | Other | +2,000 | $1.82 | $3.64K | 922,129 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 21, 2018 | Other | +600 | $2.04 | $1.22K | 923,729 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 21, 2018 | Other | +1,000 | $2.05 | $2.05K | 923,129 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 20, 2018 | Other | +400 | $2.45 | $980 | 920,129 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 19, 2018 | Other | +400 | $2.47 | $988 | 919,329 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 19, 2018 | Other | +400 | $2.45 | $980 | 919,729 |
| Zackary S. Irani Chief Executive Officer, Director | Dec 7, 2018 | Other | +33,390 | $2.70 | $90.15K | 918,929 |
| Francis Cano Director | Oct 26, 2018 | Option exercise | +25,000 | $0.75 | $18.75K | 166,736 |
| Allen Barbieri Director | Oct 19, 2018 | Option exercise | +25,000 | $0.75 | $18.75K | 160,289 |
| Jane Emerson Director | Oct 5, 2018 | Option exercise | +25,000 | $0.75 | $18.75K | 71,000 |
| Zackary S. Irani Chief Executive Officer, Director, 10% owner | May 23, 2018 | Other | +25,000 | $3.73 | $93.25K | 885,539 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Biomerica's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,582 shares on Aug 28, 2026 over the last 90 days.
See a number that looks wrong?